ATE250936T1 - Verfahren zur behandlung von erkrankungen oder störungen des innenohrs - Google Patents
Verfahren zur behandlung von erkrankungen oder störungen des innenohrsInfo
- Publication number
- ATE250936T1 ATE250936T1 AT99910259T AT99910259T ATE250936T1 AT E250936 T1 ATE250936 T1 AT E250936T1 AT 99910259 T AT99910259 T AT 99910259T AT 99910259 T AT99910259 T AT 99910259T AT E250936 T1 ATE250936 T1 AT E250936T1
- Authority
- AT
- Austria
- Prior art keywords
- inner ear
- sensory cells
- disorders
- cells
- cyclin
- Prior art date
Links
- 210000003027 ear inner Anatomy 0.000 title abstract 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title abstract 2
- 230000001953 sensory effect Effects 0.000 abstract 5
- 229940123587 Cell cycle inhibitor Drugs 0.000 abstract 2
- 230000006378 damage Effects 0.000 abstract 2
- 108010016777 Cyclin-Dependent Kinase Inhibitor p27 Proteins 0.000 abstract 1
- 102000000577 Cyclin-Dependent Kinase Inhibitor p27 Human genes 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002875 cyclin dependent kinase inhibitor Substances 0.000 abstract 1
- 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 230000001172 regenerating effect Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19807426A DE19807426A1 (de) | 1998-02-23 | 1998-02-23 | Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs |
| PCT/EP1999/001153 WO1999042088A2 (de) | 1998-02-23 | 1999-02-23 | Verfahren zur behandlung von erkrankungen oder störungen des innenohrs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE250936T1 true ATE250936T1 (de) | 2003-10-15 |
Family
ID=7858563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99910259T ATE250936T1 (de) | 1998-02-23 | 1999-02-23 | Verfahren zur behandlung von erkrankungen oder störungen des innenohrs |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7087581B1 (enExample) |
| EP (1) | EP1056467B1 (enExample) |
| JP (1) | JP2002503687A (enExample) |
| AT (1) | ATE250936T1 (enExample) |
| AU (1) | AU763868B2 (enExample) |
| CA (1) | CA2320717C (enExample) |
| DE (2) | DE19807426A1 (enExample) |
| DK (1) | DK1056467T3 (enExample) |
| ES (1) | ES2211055T3 (enExample) |
| PT (1) | PT1056467E (enExample) |
| WO (1) | WO1999042088A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2325198A1 (en) | 1999-06-01 | 2011-05-25 | Baylor College Of Medicine | Compositions and methods for the therapeutic use of an atonal-associated sequence |
| DE10027777A1 (de) * | 2000-06-07 | 2001-12-13 | Otogene Ag | Transfektionsverfahren |
| CA2412764C (en) * | 2000-07-11 | 2014-06-03 | Sound Pharmaceuticals Incorporated | Stimulation of cellular regeneration and differentiation in the inner ear |
| JP4533144B2 (ja) | 2002-10-02 | 2010-09-01 | アンジェスＭｇ株式会社 | 聴覚機能障害用医薬 |
| EP1585523B1 (en) * | 2002-12-17 | 2008-10-01 | Centre National De La Recherche Scientifique (Cnrs) | Use of purine derivatives for inducing differentiation of supernumerary hair cells and deiters' cells in the developing organ of corti for treating deafness |
| EP2293800B1 (en) | 2008-06-06 | 2016-10-05 | Quark Pharmaceuticals, Inc. | Compositions and methods for treatment of ear disorders |
| DE102010007281A1 (de) * | 2010-02-08 | 2011-08-11 | EMC microcollections GmbH, 72070 | Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger |
| RU2480195C1 (ru) * | 2011-11-02 | 2013-04-27 | Федеральное государственное учреждение "Российский научный центр восстановительной медицины и курортологии Федерального агентства по здравоохранению и социальному развитию РФ" (ФГУ "РНЦВМиК Росздрава РФ") | Способ лечения заболеваний внутреннего уха |
| EP2802657B1 (en) | 2012-01-12 | 2018-05-02 | Quark Pharmaceuticals, Inc. | Combination therapy for treating hearing and balance disorders |
| WO2013134022A1 (en) * | 2012-03-05 | 2013-09-12 | Wake Forest University Health Sciences | Regeneration of inner ear cells |
| TWI710635B (zh) | 2014-10-09 | 2020-11-21 | 美商珍維克公司 | 編碼人類無調同源物-1(hath1)之腺病毒載體 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19528388A1 (de) * | 1995-08-02 | 1997-02-06 | Hans Peter Prof Dr Med Zenner | Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs |
| EP0866716A4 (en) | 1995-11-13 | 2002-05-02 | Cambridge Neuroscience Inc | METHOD FOR TREATING DISORDERS OF THE NON-VISUAL SENSORIC EPITHEL |
| US5962224A (en) * | 1995-12-19 | 1999-10-05 | Dana-Farber Cancer Institute | Isolated DNA encoding p62 polypeptides and uses therefor |
| AU3591597A (en) | 1996-06-28 | 1998-01-21 | Regents Of The University Of California, The | Transformation and genetherapy of cells of the inner ear |
| AU4600297A (en) | 1996-09-27 | 1998-04-17 | Trustees Of The University Of Pennsylvania, The | Novel methods for inducing proliferation in auditory receptor epithelium |
| US6043221A (en) * | 1997-07-30 | 2000-03-28 | Amgen Inc. | Method for preventing and treating hearing loss using a neuturin protein product |
-
1998
- 1998-02-23 DE DE19807426A patent/DE19807426A1/de not_active Withdrawn
-
1999
- 1999-02-23 DE DE59907195T patent/DE59907195D1/de not_active Expired - Fee Related
- 1999-02-23 PT PT99910259T patent/PT1056467E/pt unknown
- 1999-02-23 WO PCT/EP1999/001153 patent/WO1999042088A2/de not_active Ceased
- 1999-02-23 DK DK99910259T patent/DK1056467T3/da active
- 1999-02-23 CA CA002320717A patent/CA2320717C/en not_active Expired - Fee Related
- 1999-02-23 ES ES99910259T patent/ES2211055T3/es not_active Expired - Lifetime
- 1999-02-23 EP EP99910259A patent/EP1056467B1/de not_active Expired - Lifetime
- 1999-02-23 US US09/622,719 patent/US7087581B1/en not_active Expired - Lifetime
- 1999-02-23 AU AU29281/99A patent/AU763868B2/en not_active Ceased
- 1999-02-23 AT AT99910259T patent/ATE250936T1/de not_active IP Right Cessation
- 1999-02-23 JP JP2000532105A patent/JP2002503687A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999042088A3 (de) | 2000-03-02 |
| EP1056467A2 (de) | 2000-12-06 |
| CA2320717C (en) | 2009-03-24 |
| WO1999042088A2 (de) | 1999-08-26 |
| DE59907195D1 (de) | 2003-11-06 |
| ES2211055T3 (es) | 2004-07-01 |
| AU2928199A (en) | 1999-09-06 |
| PT1056467E (pt) | 2004-02-27 |
| DE19807426A1 (de) | 1999-10-14 |
| CA2320717A1 (en) | 1999-08-26 |
| US7087581B1 (en) | 2006-08-08 |
| AU763868B2 (en) | 2003-07-31 |
| JP2002503687A (ja) | 2002-02-05 |
| EP1056467B1 (de) | 2003-10-01 |
| DK1056467T3 (da) | 2004-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE362363T1 (de) | Verwendung von tnf-alpha inhibitoren zur behandlung von nervenwurzelschäden | |
| PA8478501A1 (es) | Compuestos heterociclicos como inhibidores de enzimas de rotamasa | |
| EA200200847A1 (ru) | Производные пиперазина и пиперидина для лечения и профилактики поврежденных нейронов | |
| ATE323482T1 (de) | Verwendung von p38 mapk inhibitoren in der behandlung von augenkrankheiten | |
| DE60029799D1 (de) | Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe | |
| ATE395052T1 (de) | Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes | |
| ATE292462T1 (de) | Behandlung von asthma anhand von mek-inhibitoren | |
| ATE517632T1 (de) | Niedrigdosierte verfahren zur behandlung von erkrankungen, bei denen tnf-alpha-aktivität schädlich ist | |
| ATE279181T1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
| ATE361752T1 (de) | Methoden zur prophylaxe und behandlung von schäden der wahrnehmungshärchenzellen und der cochlearen neuronen | |
| ATE250936T1 (de) | Verfahren zur behandlung von erkrankungen oder störungen des innenohrs | |
| ATE315390T1 (de) | Zyklische polyamine zur behandlung der thrombozytopenie | |
| ATE260653T1 (de) | Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen | |
| DE60112766D1 (de) | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen | |
| ATE422357T1 (de) | Verwendung von allopurinol zur behandlung von bluthochdruck | |
| DE60326548D1 (de) | Verfahren zur verhütung oder behandlung von herzarrhythmie | |
| ATE541565T1 (de) | Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus | |
| DE69829202D1 (de) | Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen | |
| ATE281841T1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen | |
| DE60326742D1 (de) | Piperazin und piperadin-derivate für die behandlung von neurologischen krankheiten | |
| ATE294584T1 (de) | Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz | |
| DE69818809D1 (de) | Verfahren zur behandlung von narbengewebe | |
| ATE262362T1 (de) | Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung | |
| DE60220825D1 (de) | Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks | |
| ATE268170T1 (de) | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |